PharmaShots | Incisive News in 3 Shots

Subscribe Now

Continued Treatment

BMS' Onureg (azacitidine) Receives the US FDA's Approval as Continued Treatment for Acute Myeloid Leukemia

BMS' Onureg (azacitidine) Receives the US FDA's Approval as Continued Treatment for Acute Myeloid Leukemia

September 2, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us